Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Notable open interest changes for May 13th » 08:55
05/13/21
05/13
08:55
05/13/21
08:55
AAPL

Apple

$122.82 /

-3.02 (-2.40%)

, XOM

Exxon Mobil

$60.04 /

+0.32 (+0.54%)

, PLTR

Palantir

$18.87 /

-1.33 (-6.58%)

, FB

Facebook

$302.70 /

-3.7 (-1.21%)

Wednesday's total…

Wednesday's total option volume of 41.2 million contracts resulted in net open interest growth of 4.42 million calls and 4.43 million puts. Apple (AAPL), Exxon Mobil (XOM), Palantir Technologies (PLTR) and Facebook (FB) saw the greatest growth. Top five new positions opened include 31k Exxon Mobil (XOM) Jul-21 60 puts, 29k Exxon Mobil (XOM) Jul-21 60 calls, 23k Bank of America (BAC) Jun-21 43 calls, 23k Bank of America (BAC) Jun-21 47 calls and 21k Vipshop (VIPS) May-21 30 calls.

ShowHide Related Items >><<
XOM Exxon Mobil
$60.04 /

+0.32 (+0.54%)

PLTR Palantir
$18.87 /

-1.33 (-6.58%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

07:25 Today JPMorgan
iPhone continues to gain share in China, says JPMorgan
07:20 Today Bernstein
Bernstein sees potentially worrisome similarities between iPhone 12, iPhone 6/X
05/11/21 Evercore ISI
Chinese data points to smartphone market slowdown in April, says Evercore ISI
05/11/21 Bernstein
Mix shift to Pro/Pro Max behind Apple iPhone ASPs strength, says Bernstein
XOM Exxon Mobil
$60.04 /

+0.32 (+0.54%)

05/05/21 DZ Bank
Exxon Mobil upgraded to Buy from Hold at DZ Bank
05/03/21 Truist
Exxon Mobil price target raised to $64 from $60 at Truist
05/03/21 Mizuho
Exxon Mobil price target raised to $58 from $55 at Mizuho
04/14/21
Fly Intel: Top five analyst upgrades
PLTR Palantir
$18.87 /

-1.33 (-6.58%)

05/12/21 Wolfe Research
Palantir price target lowered to $20 from $23 at Wolfe Research
05/12/21 Morgan Stanley
Palantir building toward more durable growth, but priced in, says Morgan Stanley
05/12/21 Goldman Sachs
Goldman 'encouraged' by 'noteworthy' Q1 from Palantir, keeps Buy
05/12/21 Citi
Palantir price target raised to $17 from $15 at Citi
FB Facebook
$302.70 /

-3.7 (-1.21%)

05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
05/10/21 Citi
Facebook downgraded to Neutral from Buy at Citi
04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
XOM Exxon Mobil
$60.04 /

+0.32 (+0.54%)

PLTR Palantir
$18.87 /

-1.33 (-6.58%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

XOM Exxon Mobil
$60.04 /

+0.32 (+0.54%)

PLTR Palantir
$18.87 /

-1.33 (-6.58%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

XOM Exxon Mobil
$60.04 /

+0.32 (+0.54%)

PLTR Palantir
$18.87 /

-1.33 (-6.58%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

XOM Exxon Mobil
$60.04 /

+0.32 (+0.54%)

PLTR Palantir
$18.87 /

-1.33 (-6.58%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

Options
Facebook call buyer realizes 16% same-day gains » 08:00
05/13/21
05/13
08:00
05/13/21
08:00
FB

Facebook

$302.70 /

-3.7 (-1.21%)

Notable profits for the…

Notable profits for the buyer who lifted the $14.69 offer for 1,007 Facebook (FB) Aug-21 315 calls yesterday at 11:10ET when underlying shares were trading at $299.99. Shares closed at $302.55, and the calls at $16.98 for a mark-to-market profit of 16%, or $230K, on the $1479K outlay.

ShowHide Related Items >><<
FB Facebook
$302.70 /

-3.7 (-1.21%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
05/10/21 Citi
Facebook downgraded to Neutral from Buy at Citi
04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
FB Facebook
$302.70 /

-3.7 (-1.21%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

Yesterday
Periodicals
Facebook scrutinized in Ireland over content moderator treatment, Engadget says » 17:55
05/12/21
05/12
17:55
05/12/21
17:55
FB

Facebook

$302.70 /

-3.7 (-1.21%)

Facebook is on the hot…

Facebook is on the hot seat in Ireland after a content moderator in Ireland spoke with an Irish regulatory group about the social media giant's scant efforts to protect "the workers who sift through violent and disturbing content on the platform," wrote Engadget's Karissa Bell. "Isabella Plunkett, who currently works for Covalen, a Irish outsourcing company that hires content moderators to work as contract staff," spoke with Irish regulators about the situation, noted the Engadget story. Reference Link

ShowHide Related Items >><<
FB Facebook
$302.70 /

-3.7 (-1.21%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
05/10/21 Citi
Facebook downgraded to Neutral from Buy at Citi
04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
FB Facebook
$302.70 /

-3.7 (-1.21%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

Hot Stocks
Facebook's Diem announces partnership with Silvergate, strategic shift to U.S. » 16:26
05/12/21
05/12
16:26
05/12/21
16:26
FB

Facebook

$302.70 /

-3.7 (-1.21%)

, SI

Silvergate Capital

$80.96 /

-4.06 (-4.78%)

The Diem Association…

The Diem Association announces a partnership between its wholly-owned subsidiary, Diem Networks US, and Silvergate Capital Corporation (SI). Under this partnership, Silvergate Bank will become the exclusive issuer of the Diem USD stablecoin. The Association is also announcing a strategic shift to the United States, resulting in a move of Diem's primary operations from Switzerland to the United States. As a result, Diem is withdrawing its application for a payment system license from the Swiss Financial Markets Authority, or FINMA, as a FINMA license is not required under the new model. Silvergate is a California state-chartered bank and a member of the Federal Reserve, and Diem Networks US will register as a money services business with the US Department of the Treasury's Financial Crimes Enforcement Network. "Silvergate is a leader in financial innovation and an ideal partner for Diem as we move forward with a blockchain-based payment system that protects consumers and enhances the integrity of the financial system. We are committed to a payment system that is safe for consumers and businesses, makes payments faster and cheaper, and takes advantage of blockchain technology to bring the benefits of the financial system to more people around the world. We look forward to working with Silvergate to realize this shared vision," said Stuart Levey, CEO of Diem. Diem, formerly known as Libra, is a permissioned blockchain-based payment system proposed by Facebook (FB). Reference Link

ShowHide Related Items >><<
SI Silvergate Capital
$80.96 /

-4.06 (-4.78%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
05/10/21 Citi
Facebook downgraded to Neutral from Buy at Citi
04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
SI Silvergate Capital
$80.96 /

-4.06 (-4.78%)

04/13/21 Barclays
Silvergate Capital price target raised to $165 from $85 at Barclays
03/30/21 Canaccord
Silvergate Capital price target raised to $150 from $90 at Canaccord
03/02/21 Wedbush
Silvergate Capital price target raised to $175 from $150 at Wedbush
02/04/21 Craig-Hallum
Silvergate Capital price target raised to $135 from $80 at Craig-Hallum
SI Silvergate Capital
$80.96 /

-4.06 (-4.78%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

  • 22
    Jan
SI Silvergate Capital
$80.96 /

-4.06 (-4.78%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

SI Silvergate Capital
$80.96 /

-4.06 (-4.78%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

SI Silvergate Capital
$80.96 /

-4.06 (-4.78%)

FB Facebook
$302.70 /

-3.7 (-1.21%)

On The Fly
#SocialStocks: TikTok explores sales feature, intensifies Facebook competition » 15:54
05/12/21
05/12
15:54
05/12/21
15:54
FB

Facebook

$303.96 /

-2.44 (-0.80%)

, GOOG

Alphabet

$2,246.99 /

-62.97 (-2.73%)

, GOOGL

Alphabet Class A

$2,207.15 /

-62.45 (-2.75%)

, ROKU

Roku

$309.52 /

-4.51 (-1.44%)

, TWTR

Twitter

$50.77 /

-2.12 (-4.01%)

Welcome to…

ShowHide Related Items >><<
TWTR Twitter
$50.77 /

-2.12 (-4.01%)

ROKU Roku
$309.52 /

-4.51 (-1.44%)

GOOGL Alphabet Class A
$2,207.15 /

-62.45 (-2.75%)

GOOG Alphabet
$2,246.99 /

-62.97 (-2.73%)

FB Facebook
$303.96 /

-2.44 (-0.80%)

FB Facebook
$303.96 /

-2.44 (-0.80%)

05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
05/10/21 Citi
Facebook downgraded to Neutral from Buy at Citi
04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
GOOG Alphabet
$2,246.99 /

-62.97 (-2.73%)

05/10/21 Citi
Citi downgrades Google and Facebook on bullish sell-side expectations
05/03/21
Fly Intel: Top five analyst upgrades
GOOGL Alphabet Class A
$2,207.15 /

-62.45 (-2.75%)

05/10/21 Citi
ViacomCBS added, Google removed from Citi's Recommended List
ROKU Roku
$309.52 /

-4.51 (-1.44%)

05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
05/07/21 Evercore ISI
Roku price target raised to $430 from $400 at Evercore ISI
05/07/21 KeyBanc
Roku price target lowered to $460 from $518 at KeyBanc
TWTR Twitter
$50.77 /

-2.12 (-4.01%)

05/10/21 Citi
Twitter price target lowered to $58 from $80 at Citi
05/03/21 BMO Capital
Twitter price target lowered to $65 from $80 at BMO Capital
04/30/21 MKM Partners
Twitter price target lowered to $83 from $95 at MKM Partners
04/30/21 JPMorgan
Twitter earnings selloff a buying opportunity, says JPMorgan
TWTR Twitter
$50.77 /

-2.12 (-4.01%)

ROKU Roku
$309.52 /

-4.51 (-1.44%)

GOOG Alphabet
$2,246.99 /

-62.97 (-2.73%)

FB Facebook
$303.96 /

-2.44 (-0.80%)

TWTR Twitter
$50.77 /

-2.12 (-4.01%)

ROKU Roku
$309.52 /

-4.51 (-1.44%)

GOOGL Alphabet Class A
$2,207.15 /

-62.45 (-2.75%)

GOOG Alphabet
$2,246.99 /

-62.97 (-2.73%)

FB Facebook
$303.96 /

-2.44 (-0.80%)

TWTR Twitter
$50.77 /

-2.12 (-4.01%)

ROKU Roku
$309.52 /

-4.51 (-1.44%)

GOOG Alphabet
$2,246.99 /

-62.97 (-2.73%)

FB Facebook
$303.96 /

-2.44 (-0.80%)

TWTR Twitter
$50.77 /

-2.12 (-4.01%)

ROKU Roku
$309.52 /

-4.51 (-1.44%)

GOOGL Alphabet Class A
$2,207.15 /

-62.45 (-2.75%)

GOOG Alphabet
$2,246.99 /

-62.97 (-2.73%)

FB Facebook
$303.96 /

-2.44 (-0.80%)

Tuesday
Periodicals
TikTok tests in-app sales feature in Europe, Bloomberg reports » 14:15
05/11/21
05/11
14:15
05/11/21
14:15
FB

Facebook

$305.60 /

-0.48 (-0.16%)

, ORCL

Oracle

$77.66 /

-2.5 (-3.12%)

, WMT

Walmart

$138.84 /

-1.95 (-1.39%)

ByteDance's TikTok…

ByteDance's TikTok is working with brands, such as streetwear company Hype, to test an in-app sales feature in Europe, a move that could potentially rival similar offerings from Facebook (FB), Bloomberg's Coco Liu, Zheping Huang, and Giles Turner report. The video sharing app is seeking to replicate the success of China's Douyin, which brought in $26B in e-commerce transactions in just its first year of operation, the authors note. TikTok has started working with merchants in markets such as the U.K. on ways they can sell products directly to TikTok users within the app, the authors say, citing people familiar with the matter. Previously it had been reported that ByteDance had been in extended talks with Walmart (WMT) and Oracle (ORCL) to finalize a move of TikTok's U.S. operations into a new entity. Reference Link

ShowHide Related Items >><<
WMT Walmart
$138.84 /

-1.95 (-1.39%)

ORCL Oracle
$77.66 /

-2.5 (-3.12%)

FB Facebook
$305.60 /

-0.48 (-0.16%)

FB Facebook
$305.60 /

-0.48 (-0.16%)

05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
05/10/21 Citi
Facebook downgraded to Neutral from Buy at Citi
04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
ORCL Oracle
$77.66 /

-2.5 (-3.12%)

05/10/21 Barclays
Oracle downgraded to Equal Weight from Overweight at Barclays
04/22/21 Wolfe Research
Oracle initiated with a Peer Perform at Wolfe Research
04/22/21 Cowen
Oracle price target raised to $85 from $77 at Cowen
WMT Walmart
$138.84 /

-1.95 (-1.39%)

05/10/21 Morgan Stanley
Survey data points to uptick in Walmart+ membership, says Morgan Stanley
04/23/21 Cowen
Walmart+ members may have declined to 11.1M in March, says Cowen
04/06/21 Morgan Stanley
Walmart+ membership 'seems to have stagnated,' says Morgan Stanley
03/16/21 MKM Partners
Walmart price target lowered to $141 from $154 at MKM Partners
WMT Walmart
$138.84 /

-1.95 (-1.39%)

ORCL Oracle
$77.66 /

-2.5 (-3.12%)

FB Facebook
$305.60 /

-0.48 (-0.16%)

WMT Walmart
$138.84 /

-1.95 (-1.39%)

ORCL Oracle
$77.66 /

-2.5 (-3.12%)

FB Facebook
$305.60 /

-0.48 (-0.16%)

WMT Walmart
$138.84 /

-1.95 (-1.39%)

ORCL Oracle
$77.66 /

-2.5 (-3.12%)

FB Facebook
$305.60 /

-0.48 (-0.16%)

WMT Walmart
$138.84 /

-1.95 (-1.39%)

ORCL Oracle
$77.66 /

-2.5 (-3.12%)

FB Facebook
$305.60 /

-0.48 (-0.16%)

Periodicals
Germany prohibits Facebook from processing WhatsApp data, Reuters says » 11:01
05/11/21
05/11
11:01
05/11/21
11:01
FB

Facebook

$300.88 /

-5.2 (-1.70%)

Germany's data…

Germany's data protection regulator for Facebook is prohibiting the site from processing personal information from WhatsApp users as it sees the app's new terms of use as illegal, Reuters reports, citing the Hamburg data protection authority. "This order seeks to secure the rights and freedoms of the many millions of users who give their consent to the terms of use throughout Germany," Hamburg's data protection officer Johannes Caspar said. "My objective is to prevent disadvantages and damages associated with such a black-box procedure." Reference Link

ShowHide Related Items >><<
FB Facebook
$300.88 /

-5.2 (-1.70%)

FB Facebook
$300.88 /

-5.2 (-1.70%)

05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
05/10/21 Citi
Facebook downgraded to Neutral from Buy at Citi
04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
FB Facebook
$300.88 /

-5.2 (-1.70%)

FB Facebook
$300.88 /

-5.2 (-1.70%)

FB Facebook
$300.88 /

-5.2 (-1.70%)

FB Facebook
$300.88 /

-5.2 (-1.70%)

Monday
On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:56
05/10/21
05/10
16:56
05/10/21
16:56
BNTX

BioNTech

$202.59 /

+19.02 (+10.36%)

, PFE

Pfizer

$39.87 /

+0.3 (+0.76%)

, INO

Inovio

$6.70 /

-0.14 (-2.05%)

, NVAX

Novavax

$160.40 /

-15.22 (-8.67%)

, FEYE

FireEye

$19.53 /

+0.22 (+1.14%)

, CRWD

Crowdstrike

$187.33 /

-1.57 (-0.83%)

, PANW

Palo Alto Networks

$341.36 /

-0.985 (-0.29%)

, TENB

Tenable Holdings

$37.37 /

+0.24 (+0.65%)

, GOOG

Alphabet

$2,342.66 /

-55.73 (-2.32%)

, GOOGL

Alphabet Class A

$2,291.86 /

-59.4 (-2.53%)

, ROKU

Roku

$301.23 /

-15.75 (-4.97%)

, FB

Facebook

$305.98 /

-13.02 (-4.08%)

, DUK

Duke Energy

$103.75 /

+2.85 (+2.82%)

, SWBK

Switchback II

$9.99 /

+0.06 (+0.60%)

, CUE

Cue Biopharma

$14.38 /

+3.21 (+28.74%)

, SOLY

Soliton

$22.40 /

+4.4 (+24.44%)

, ABBV

AbbVie

$116.20 /

+0.44 (+0.38%)

, TTD

Trade Desk

$488.00 /

-174.36 (-26.32%)

, INSM

Insmed

$25.99 /

-6.59 (-20.23%)

The major averages had a…

ShowHide Related Items >><<
TTD Trade Desk
$488.00 /

-174.36 (-26.32%)

TENB Tenable Holdings
$37.37 /

+0.24 (+0.65%)

SOLY Soliton
$22.40 /

+4.4 (+24.44%)

ROKU Roku
$301.23 /

-15.75 (-4.97%)

PFE Pfizer
$39.87 /

+0.3 (+0.76%)

PANW Palo Alto Networks
$341.36 /

-0.985 (-0.29%)

NVAX Novavax
$160.40 /

-15.22 (-8.67%)

INSM Insmed
$25.99 /

-6.59 (-20.23%)

INO Inovio
$6.70 /

-0.14 (-2.05%)

GOOGL Alphabet Class A
$2,291.86 /

-59.4 (-2.53%)

GOOG Alphabet
$2,342.66 /

-55.73 (-2.32%)

FEYE FireEye
$19.53 /

+0.22 (+1.14%)

FB Facebook
$305.98 /

-13.02 (-4.08%)

DUK Duke Energy
$103.75 /

+2.85 (+2.82%)

CUE Cue Biopharma
$14.38 /

+3.21 (+28.74%)

CRWD Crowdstrike
$187.33 /

-1.57 (-0.83%)

BNTX BioNTech
$202.59 /

+19.02 (+10.36%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

BNTX BioNTech
$202.59 /

+19.02 (+10.36%)

05/11/21 Bryan Garnier
BioNTech downgraded to Neutral from Buy at Bryan Garnier
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
PFE Pfizer
$39.87 /

+0.3 (+0.76%)

05/10/21 Morgan Stanley
Pfizer price target raised to $42 from $38 at Morgan Stanley
05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
INO Inovio
$6.70 /

-0.14 (-2.05%)

05/10/21 Piper Sandler
Inovio price target lowered to $6 from $7 at Piper Sandler
05/10/21 Piper Sandler
Inovio Phase 2 data for INO-4800 'lackluster,' says Piper Sandler
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/23/21 Oppenheimer
Oppenheimer still bullish on Inovio after U.S. discontinues trial funding
NVAX Novavax
$160.40 /

-15.22 (-8.67%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
FEYE FireEye
$19.53 /

+0.22 (+1.14%)

05/10/21 Goldman Sachs
FireEye could be direct beneficiary of pipeline cyberattack, says Goldman Sachs
02/04/21
Fly Intel: Top five analyst upgrades
02/04/21 BofA
FireEye upgraded to Buy on 'solid execution' at BofA
02/04/21 BofA
FireEye upgraded to Buy from Neutral at BofA
CRWD Crowdstrike
$187.33 /

-1.57 (-0.83%)

04/21/21 Berenberg
Crowdstrike initiated with a Buy at Berenberg
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 Deutsche Bank
Deutsche starts Crowdstrike with Buy rating, $265 price target
PANW Palo Alto Networks
$341.36 /

-0.985 (-0.29%)

04/23/21 KeyBanc
Palo Alto Networks price target raised to $469 from $450 at KeyBanc
04/05/21 Credit Suisse
Palo Alto Networks assumed with an Outperform at Credit Suisse
03/18/21 Mizuho
Palo Alto thesis intact after 'surprising' CFO exit, says Mizuho
TENB Tenable Holdings
$37.37 /

+0.24 (+0.65%)

02/22/21 Barclays
Tenable Holdings initiated with an Overweight at Barclays
02/17/21 Stifel
Tenable Holdings resumed with a Buy at Stifel
02/16/21 Canaccord
Tenable Holdings initiated with a Buy at Canaccord
GOOG Alphabet
$2,342.66 /

-55.73 (-2.32%)

05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Citi downgrades Google and Facebook on bullish sell-side expectations
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
05/03/21
Fly Intel: Top five analyst upgrades
GOOGL Alphabet Class A
$2,291.86 /

-59.4 (-2.53%)

05/10/21 Citi
ViacomCBS added, Google removed from Citi's Recommended List
ROKU Roku
$301.23 /

-15.75 (-4.97%)

05/07/21 Evercore ISI
Roku price target raised to $430 from $400 at Evercore ISI
05/07/21 KeyBanc
Roku price target lowered to $460 from $518 at KeyBanc
05/07/21 Oppenheimer
Roku price target lowered to $400 from $500 at Oppenheimer
FB Facebook
$305.98 /

-13.02 (-4.08%)

05/10/21 Citi
Facebook downgraded to Neutral from Buy at Citi
04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
DUK Duke Energy
$103.75 /

+2.85 (+2.82%)

04/14/21 Credit Suisse
Duke Energy price target raised to $104 from $96 at Credit Suisse
04/14/21 Wells Fargo
Duke Energy price target raised to $104 from $97 at Wells Fargo
02/12/21 BofA
Duke Energy downgraded to Neutral from Buy at BofA
02/01/21 Mizuho
Duke Energy price target raised to $96 from $93 at Mizuho
SWBK Switchback II
$9.99 /

+0.06 (+0.60%)

CUE Cue Biopharma
$14.38 /

+3.21 (+28.74%)

11/24/20 Berenberg
Cue Biopharma initiated with a Buy at Berenberg
05/20/20 Oppenheimer
Cue Biopharma price target raised to $32 from $27 at Oppenheimer
05/20/20 BTIG
Cue Biopharma price target raised to $33 from $26 at BTIG
SOLY Soliton
$22.40 /

+4.4 (+24.44%)

05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/10/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
04/30/21 Piper Sandler
AbbVie price target raised to $124 from $120 at Piper Sandler
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
TTD Trade Desk
$488.00 /

-174.36 (-26.32%)

05/11/21 Wells Fargo
Trade Desk price target lowered to $750 from $1,000 at Wells Fargo
05/11/21 KeyBanc
Trade Desk price target lowered to $740 from $851 at KeyBanc
05/11/21 Oppenheimer
Trade Desk price target lowered to $600 from $950 at Oppenheimer
05/11/21 Stifel
Trade Desk price target lowered to $650 from $700 at Stifel
INSM Insmed
$25.99 /

-6.59 (-20.23%)

04/26/21 Credit Suisse
Insmed assumed with an Outperform at Credit Suisse
02/22/21 Credit Suisse
United Therapeutics price target raised to $196 from $169 at Credit Suisse
01/19/21 Credit Suisse
Insmed price target raised to $60 from $50 at Credit Suisse
12/17/20 Berenberg
Insmed initiated with a Buy at Berenberg
TTD Trade Desk
$488.00 /

-174.36 (-26.32%)

TENB Tenable Holdings
$37.37 /

+0.24 (+0.65%)

SOLY Soliton
$22.40 /

+4.4 (+24.44%)

ROKU Roku
$301.23 /

-15.75 (-4.97%)

PFE Pfizer
$39.87 /

+0.3 (+0.76%)

PANW Palo Alto Networks
$341.36 /

-0.985 (-0.29%)

NVAX Novavax
$160.40 /

-15.22 (-8.67%)

INSM Insmed
$25.99 /

-6.59 (-20.23%)

INO Inovio
$6.70 /

-0.14 (-2.05%)

GOOG Alphabet
$2,342.66 /

-55.73 (-2.32%)

FEYE FireEye
$19.53 /

+0.22 (+1.14%)

FB Facebook
$305.98 /

-13.02 (-4.08%)

DUK Duke Energy
$103.75 /

+2.85 (+2.82%)

CUE Cue Biopharma
$14.38 /

+3.21 (+28.74%)

CRWD Crowdstrike
$187.33 /

-1.57 (-0.83%)

BNTX BioNTech
$202.59 /

+19.02 (+10.36%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

  • 11
    May
  • 21
    Jan
  • 31
    Jul
  • 23
    Jul
  • 26
    Jun
  • 26
    Jun
TTD Trade Desk
$488.00 /

-174.36 (-26.32%)

SWBK Switchback II
$9.99 /

+0.06 (+0.60%)

ROKU Roku
$301.23 /

-15.75 (-4.97%)

PFE Pfizer
$39.87 /

+0.3 (+0.76%)

PANW Palo Alto Networks
$341.36 /

-0.985 (-0.29%)

NVAX Novavax
$160.40 /

-15.22 (-8.67%)

GOOG Alphabet
$2,342.66 /

-55.73 (-2.32%)

FEYE FireEye
$19.53 /

+0.22 (+1.14%)

FB Facebook
$305.98 /

-13.02 (-4.08%)

DUK Duke Energy
$103.75 /

+2.85 (+2.82%)

BNTX BioNTech
$202.59 /

+19.02 (+10.36%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

TTD Trade Desk
$488.00 /

-174.36 (-26.32%)

TENB Tenable Holdings
$37.37 /

+0.24 (+0.65%)

ROKU Roku
$301.23 /

-15.75 (-4.97%)

PFE Pfizer
$39.87 /

+0.3 (+0.76%)

PANW Palo Alto Networks
$341.36 /

-0.985 (-0.29%)

NVAX Novavax
$160.40 /

-15.22 (-8.67%)

INO Inovio
$6.70 /

-0.14 (-2.05%)

GOOG Alphabet
$2,342.66 /

-55.73 (-2.32%)

FEYE FireEye
$19.53 /

+0.22 (+1.14%)

FB Facebook
$305.98 /

-13.02 (-4.08%)

CUE Cue Biopharma
$14.38 /

+3.21 (+28.74%)

CRWD Crowdstrike
$187.33 /

-1.57 (-0.83%)

BNTX BioNTech
$202.59 /

+19.02 (+10.36%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

TTD Trade Desk
$488.00 /

-174.36 (-26.32%)

ROKU Roku
$301.23 /

-15.75 (-4.97%)

PFE Pfizer
$39.87 /

+0.3 (+0.76%)

PANW Palo Alto Networks
$341.36 /

-0.985 (-0.29%)

NVAX Novavax
$160.40 /

-15.22 (-8.67%)

INO Inovio
$6.70 /

-0.14 (-2.05%)

GOOGL Alphabet Class A
$2,291.86 /

-59.4 (-2.53%)

GOOG Alphabet
$2,342.66 /

-55.73 (-2.32%)

FEYE FireEye
$19.53 /

+0.22 (+1.14%)

FB Facebook
$305.98 /

-13.02 (-4.08%)

DUK Duke Energy
$103.75 /

+2.85 (+2.82%)

CRWD Crowdstrike
$187.33 /

-1.57 (-0.83%)

BNTX BioNTech
$202.59 /

+19.02 (+10.36%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:34
05/10/21
05/10
12:34
05/10/21
12:34
NVAX

Novavax

$165.47 /

-10.15 (-5.78%)

, GOOG

Alphabet

$2,357.00 /

-41.39 (-1.73%)

, INSM

Insmed

$25.73 /

-6.85 (-21.03%)

, TTD

Trade Desk

$525.49 /

-136.87 (-20.66%)

, ABBV

AbbVie

$116.38 /

+0.62 (+0.54%)

, SOLY

Soliton

$22.48 /

+4.48 (+24.89%)

, CUE

Cue Biopharma

$14.46 /

+3.29 (+29.45%)

, FEYE

FireEye

$20.26 /

+0.95 (+4.92%)

, ENR

Energizer

$50.92 /

+0.47 (+0.93%)

, FB

Facebook

$308.63 /

-10.37 (-3.25%)

, GOOGL

Alphabet Class A

$2,313.13 /

-38.13 (-1.62%)

, INO

Inovio

$6.91 /

+0.07 (+1.02%)

, PFE

Pfizer

$40.13 /

+0.56 (+1.42%)

, BNTX

BioNTech

$195.30 /

+11.73 (+6.39%)

The major averages are…

ShowHide Related Items >><<
TTD Trade Desk
$525.49 /

-136.87 (-20.66%)

SOLY Soliton
$22.48 /

+4.48 (+24.89%)

PFE Pfizer
$40.13 /

+0.56 (+1.42%)

NVAX Novavax
$165.47 /

-10.15 (-5.78%)

INSM Insmed
$25.73 /

-6.85 (-21.03%)

INO Inovio
$6.91 /

+0.07 (+1.02%)

GOOGL Alphabet Class A
$2,313.13 /

-38.13 (-1.62%)

GOOG Alphabet
$2,357.00 /

-41.39 (-1.73%)

FEYE FireEye
$20.26 /

+0.95 (+4.92%)

FB Facebook
$308.63 /

-10.37 (-3.25%)

ENR Energizer
$50.92 /

+0.47 (+0.93%)

CUE Cue Biopharma
$14.46 /

+3.29 (+29.45%)

BNTX BioNTech
$195.30 /

+11.73 (+6.39%)

ABBV AbbVie
$116.38 /

+0.62 (+0.54%)

NVAX Novavax
$165.47 /

-10.15 (-5.78%)

04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
GOOG Alphabet
$2,357.00 /

-41.39 (-1.73%)

05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Citi downgrades Google and Facebook on bullish sell-side expectations
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
05/03/21
Fly Intel: Top five analyst upgrades
INSM Insmed
$25.73 /

-6.85 (-21.03%)

04/26/21 Credit Suisse
Insmed assumed with an Outperform at Credit Suisse
02/22/21 Credit Suisse
United Therapeutics price target raised to $196 from $169 at Credit Suisse
01/19/21 Credit Suisse
Insmed price target raised to $60 from $50 at Credit Suisse
12/17/20 Berenberg
Insmed initiated with a Buy at Berenberg
TTD Trade Desk
$525.49 /

-136.87 (-20.66%)

04/21/21 Vertical Group
Trade Desk upgraded to Positive from Mixed at Vertical Group
04/05/21 Evercore ISI
Trade Desk initiated with an Outperform at Evercore ISI
03/08/21 Oppenheimer
Too soon to tell impact of Chrome policy changes on e-commerce, says Oppenheimer
03/08/21 KeyBanc
Trade Desk upgraded to Overweight from Sector Weight at KeyBanc
ABBV AbbVie
$116.38 /

+0.62 (+0.54%)

05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
04/30/21 Piper Sandler
AbbVie price target raised to $124 from $120 at Piper Sandler
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day positive catalyst' on AbbVie, reiterates Buy rating
SOLY Soliton
$22.48 /

+4.48 (+24.89%)

05/10/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
02/02/21 Cantor Fitzgerald
Soliton price target raised to $20 from $12 at Cantor Fitzgerald
CUE Cue Biopharma
$14.46 /

+3.29 (+29.45%)

11/24/20 Berenberg
Cue Biopharma initiated with a Buy at Berenberg
05/20/20 Oppenheimer
Cue Biopharma price target raised to $32 from $27 at Oppenheimer
05/20/20 BTIG
Cue Biopharma price target raised to $33 from $26 at BTIG
FEYE FireEye
$20.26 /

+0.95 (+4.92%)

05/10/21 Goldman Sachs
FireEye could be direct beneficiary of pipeline cyberattack, says Goldman Sachs
02/04/21
Fly Intel: Top five analyst upgrades
02/04/21 BofA
FireEye upgraded to Buy on 'solid execution' at BofA
02/04/21 BofA
FireEye upgraded to Buy from Neutral at BofA
ENR Energizer
$50.92 /

+0.47 (+0.93%)

05/03/21 Deutsche Bank
Energizer price target raised to $56 from $54 at Deutsche Bank
04/16/21 JPMorgan
Energizer price target raised to $52 from $51 at JPMorgan
02/24/21
Fly Intel: Top five analyst downgrades
02/24/21 Goldman Sachs
Energizer downgraded to Neutral from Buy at Goldman Sachs
FB Facebook
$308.63 /

-10.37 (-3.25%)

05/10/21 Citi
Facebook downgraded to Neutral from Buy at Citi
04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
GOOGL Alphabet Class A
$2,313.13 /

-38.13 (-1.62%)

05/10/21 Citi
Alphabet Class A downgraded to Neutral from Buy at Citi
INO Inovio
$6.91 /

+0.07 (+1.02%)

05/10/21 Piper Sandler
Inovio Phase 2 data for INO-4800 'lackluster,' says Piper Sandler
04/23/21 Oppenheimer
Oppenheimer still bullish on Inovio after U.S. discontinues trial funding
04/23/21 Piper Sandler
Piper 'incrementally cautious' on Inovio, says today's selloff appropriate
PFE Pfizer
$40.13 /

+0.56 (+1.42%)

05/10/21 Morgan Stanley
Pfizer price target raised to $42 from $38 at Morgan Stanley
05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
BNTX BioNTech
$195.30 /

+11.73 (+6.39%)

02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
TTD Trade Desk
$525.49 /

-136.87 (-20.66%)

SOLY Soliton
$22.48 /

+4.48 (+24.89%)

PFE Pfizer
$40.13 /

+0.56 (+1.42%)

NVAX Novavax
$165.47 /

-10.15 (-5.78%)

INSM Insmed
$25.73 /

-6.85 (-21.03%)

INO Inovio
$6.91 /

+0.07 (+1.02%)

GOOG Alphabet
$2,357.00 /

-41.39 (-1.73%)

FEYE FireEye
$20.26 /

+0.95 (+4.92%)

FB Facebook
$308.63 /

-10.37 (-3.25%)

ENR Energizer
$50.92 /

+0.47 (+0.93%)

CUE Cue Biopharma
$14.46 /

+3.29 (+29.45%)

BNTX BioNTech
$195.30 /

+11.73 (+6.39%)

ABBV AbbVie
$116.38 /

+0.62 (+0.54%)

  • 11
    May
  • 21
    Jan
  • 23
    Jul
  • 26
    Jun
TTD Trade Desk
$525.49 /

-136.87 (-20.66%)

PFE Pfizer
$40.13 /

+0.56 (+1.42%)

NVAX Novavax
$165.47 /

-10.15 (-5.78%)

GOOG Alphabet
$2,357.00 /

-41.39 (-1.73%)

FEYE FireEye
$20.26 /

+0.95 (+4.92%)

FB Facebook
$308.63 /

-10.37 (-3.25%)

ENR Energizer
$50.92 /

+0.47 (+0.93%)

BNTX BioNTech
$195.30 /

+11.73 (+6.39%)

ABBV AbbVie
$116.38 /

+0.62 (+0.54%)

TTD Trade Desk
$525.49 /

-136.87 (-20.66%)

PFE Pfizer
$40.13 /

+0.56 (+1.42%)

NVAX Novavax
$165.47 /

-10.15 (-5.78%)

INO Inovio
$6.91 /

+0.07 (+1.02%)

GOOG Alphabet
$2,357.00 /

-41.39 (-1.73%)

FEYE FireEye
$20.26 /

+0.95 (+4.92%)

FB Facebook
$308.63 /

-10.37 (-3.25%)

ENR Energizer
$50.92 /

+0.47 (+0.93%)

CUE Cue Biopharma
$14.46 /

+3.29 (+29.45%)

ABBV AbbVie
$116.38 /

+0.62 (+0.54%)

TTD Trade Desk
$525.49 /

-136.87 (-20.66%)

PFE Pfizer
$40.13 /

+0.56 (+1.42%)

NVAX Novavax
$165.47 /

-10.15 (-5.78%)

INO Inovio
$6.91 /

+0.07 (+1.02%)

GOOGL Alphabet Class A
$2,313.13 /

-38.13 (-1.62%)

GOOG Alphabet
$2,357.00 /

-41.39 (-1.73%)

FEYE FireEye
$20.26 /

+0.95 (+4.92%)

FB Facebook
$308.63 /

-10.37 (-3.25%)

BNTX BioNTech
$195.30 /

+11.73 (+6.39%)

ABBV AbbVie
$116.38 /

+0.62 (+0.54%)

Hot Stocks
44 attorneys general urge Facebook to abandon Instagram for children » 10:13
05/10/21
05/10
10:13
05/10/21
10:13
FB

Facebook

$309.64 /

-9.36 (-2.93%)

New York Attorney General…

New York Attorney General Letitia James sent a letter to Facebook CEO Mark Zuckerberg urging him to abandon plans to launch a version of Instagram for children under the age of 13. A coalition of 44 attorneys general contends that social media "can be detrimental to children for myriad reasons and that Facebook has historically failed to protect the welfare of children on its platforms," James said in a statement. "Without a doubt, this is a dangerous idea that risks the safety of our children and puts them directly in harm's way," said James. Reference Link

ShowHide Related Items >><<
FB Facebook
$309.64 /

-9.36 (-2.93%)

FB Facebook
$309.64 /

-9.36 (-2.93%)

05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
05/10/21 Citi
Facebook downgraded to Neutral from Buy at Citi
04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
FB Facebook
$309.64 /

-9.36 (-2.93%)

FB Facebook
$309.64 /

-9.36 (-2.93%)

FB Facebook
$309.64 /

-9.36 (-2.93%)

FB Facebook
$309.64 /

-9.36 (-2.93%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.